Header Image
News Room / SeeThruEquity

SeeThruEquity

RSS Feed

SeeThruEquity Issues Update Note on India Globalization Capital (IGC) with Target Price of $1.20
10/20/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Update Note on Endonovo Therapeutics (ENDV) Positive Pre-Clinical Trial Results and Increases Target Price to $0.25
10/19/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Company Note on Cemtrex, Inc. Highlighting Company's Position in EMS Space
10/18/2017 -- 9:30 AM -- SeeThruEquity

SeeThruEquity Issues Update on Endonovo Therapeutics (ENDV) with Target Price of $0.20
10/13/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI)
10/10/2017 -- 9:30 AM -- SeeThruEquity

SeeThruEquity Initiates Coverage on ADOMANI, Inc. with a Price Target of $10.20
10/10/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX)
10/9/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Initiates Coverage on Cemtrex, Inc. with a Price Target of $6.45
10/5/2017 -- 9:15 AM -- SeeThruEquity

SeeThruEquity Issues Company Update on Apricus Biosciences (NASDAQ:APRI) with Target Price of $4.30
10/3/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Company Update on Vitality Biopharma, Inc. (VBIO)
9/27/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Issues Update on Yangtze River Development Ltd., Raising Price Target to $23.00
9/26/2017 -- 5:16 PM -- SeeThruEquity

SeeThruEquity Issues Company Update on Net Element
9/26/2017 -- 9:00 AM -- SeeThruEquity

SeeThruEquity Initiates Coverage on LongFin Corp. with a Price Target of $8.42
9/7/2017 -- 9:40 AM -- SeeThruEquity

Top